These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32402684)

  • 1. A randomized controlled trial comparing oral and intravenous iron supplementation after Roux-en-Y gastric bypass surgery.
    Schijns W; Boerboom A; de Bruyn Kops M; de Raaff C; van Wagensveld B; Berends FJ; Janssen IMC; van Laarhoven CJHM; de Boer H; Aarts EO
    Clin Nutr; 2020 Dec; 39(12):3779-3785. PubMed ID: 32402684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
    Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of iron deficiency and anemia after Roux-en-Y gastric bypass surgery: an observational study.
    Malone M; Alger-Mayer S; Lindstrom J; Bailie GR
    Surg Obes Relat Dis; 2013; 9(6):969-74. PubMed ID: 23499191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
    Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Iron Absorption After Roux-en-Y Gastric Bypass.
    Schijns W; Ligthart MAP; Berends FJ; Janssen IMC; van Laarhoven CJHM; Aarts EO; de Boer H
    Obes Surg; 2018 Jun; 28(6):1738-1744. PubMed ID: 29327182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting iron absorption from an effervescent iron supplement in obese patients before and after Roux-en-Y gastric bypass: a preliminary study.
    Gesquiere I; Steenackers N; Lannoo M; Foulon V; Mertens A; Gils A; de Hoon J; Augustijns P; Matthys C; Van der Schueren B
    J Trace Elem Med Biol; 2019 Mar; 52():68-73. PubMed ID: 30732902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
    Bisbe E; Moltó L; Arroyo R; Muniesa JM; Tejero M
    Br J Anaesth; 2014 Sep; 113(3):402-9. PubMed ID: 24780615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Oral Iron Supplement Formulations for Normalization of Iron Status Following Roux-EN-y Gastric Bypass Surgery: a Randomized Trial.
    Mischler RA; Armah SM; Craig BA; Rosen AD; Banerjee A; Selzer DJ; Choi JN; Gletsu-Miller N
    Obes Surg; 2018 Feb; 28(2):369-377. PubMed ID: 28779269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J;
    J Perinat Med; 2017 May; 45(4):443-453. PubMed ID: 27278921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial.
    Drexler C; Macher S; Lindenau I; Holter M; Moritz M; Stojakovic T; Pieber TR; Schlenke P; Amrein K
    Clin Nutr; 2020 Mar; 39(3):737-745. PubMed ID: 30981629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients.
    Malone M; Barish C; He A; Bregman D
    Obes Surg; 2013 Sep; 23(9):1413-20. PubMed ID: 23553506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients.
    Borstlap WAA; Buskens CJ; Tytgat KMAJ; Tuynman JB; Consten ECJ; Tolboom RC; Heuff G; van Geloven N; van Wagensveld BA; C A Wientjes CA; Gerhards MF; de Castro SMM; Jansen J; van der Ven AWH; van der Zaag E; Omloo JM; van Westreenen HL; Winter DC; Kennelly RP; Dijkgraaf MGW; Tanis PJ; Bemelman WA
    BMC Surg; 2015 Jun; 15():78. PubMed ID: 26123286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB; Jaju PB
    BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Epoetin-α with Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial.
    Biboulet P; Bringuier S; Smilevitch P; Loupec T; Thuile C; Pencole M; Maissiat G; Dangelser G; Capdevila X
    Anesthesiology; 2018 Oct; 129(4):710-720. PubMed ID: 30074935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
    Van Wyck DB; Martens MG; Seid MH; Baker JB; Mangione A
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):267-78. PubMed ID: 17666600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
    Macdougall IC; Bock AH; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Meier Y; Larroque S; Roger SD;
    BMC Nephrol; 2017 Jan; 18(1):24. PubMed ID: 28095881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron Deficiency and Anemia 10 Years After Roux-en-Y Gastric Bypass for Severe Obesity.
    Sandvik J; Bjerkan KK; Græslie H; Hoff DAL; Johnsen G; Klöckner C; Mårvik R; Nymo S; Hyldmo ÅA; Kulseng BE
    Front Endocrinol (Lausanne); 2021; 12():679066. PubMed ID: 34630319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
    Shim JY; Kim MY; Kim YJ; Lee Y; Lee JJ; Jun JK; Shin JC; Cho YK; Lee KY; Kim A; Song TB
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):349. PubMed ID: 30153811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
    Macher S; Drexler C; Lindenau I; Sareban N; Schlenke P; Amrein K
    Trials; 2016 Oct; 17(1):527. PubMed ID: 27793204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations.
    Schatz U; Arneth B; Siegert G; Siegels D; Fischer S; Julius U; Bornstein SR
    Atheroscler Suppl; 2013 Jan; 14(1):115-22. PubMed ID: 23357152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.